Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridorin for diabetic kidney disease in type 2 diabetes
ACTRN12608000406303Phase 2Completed
- Sponsor
- Medpace
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised trial of pyridorin in diabetic glomerulosclerosis and type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Medpace. Primary endpoint: Serum creatinine change from baseline to endpoint. Started Oct 2008; status: completed.
02
Drugs
pyridorin
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12608000406303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000406303.